12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Other News

Amarin cardiovascular news

Amarin said the U.S. Patent and Trademark Office (PTO) issued a notice of allowance for Patent Application No. 13/623,450. The patent covers claims for Vascepa icosapent ethyl (formerly AMR101) to treat hypertriglyceridemia - its approved indication. The application claims cover the use...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >